Back to dashboard
CommercialCoverageMedium impact

08.02.39a, Zanidatamab-hrii (Ziihera®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Jul 1, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new commercial policy for Zanidatamab-hrii (Ziihera®), a pharmacy medication, has been updated and is effective July 1, 2025. This appears to be a coverage policy for a specialized oncology drug that may affect billing and prior authorization requirements.

Action Required

Action needed
By July 1, 2025: Review the full policy details at the provided URL to determine specific prior authorization, coverage criteria, and billing requirements for Zanidatamab-hrii (Ziihera®). Update billing system and provider workflows accordingly based on the complete policy requirements.

Related policy hubs